The use of angiogenic and antiangiogenic factors in the differential diagnosis of pre-eclampsia, antiphospholipid syndrome nephropathy and lupus nephritis

Lupus

Volumn 23, Issue 12, 2014, Pages 1299-1301

  De Jesus, G R ^a   De Jesus, N R ^a   Levy, R A ^b   Klumb, E M ^b  

^a HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Angiogenic factors; antiangiogenic factors; antiphospholipid Syndrome; erythematosus; pre eclampsia; pregnancy; systemic Lupus

Indexed keywords

ANGIOGENIC FACTOR; ANTIANGIOGENIC FACTOR; CD135 ANTIGEN; ENDOGLIN; GROWTH FACTOR; PLACENTAL GROWTH FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; FLT1 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; PIGF PROTEIN, HUMAN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1;

ANTIPHOSPHOLIPID SYNDROME; ANTIPHOSPHOLIPID SYNDROME NEPHROPATHY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL (TOPIC); DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HYPERTENSION; KIDNEY DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; PROTEIN BLOOD LEVEL; PROTEINURIA; BLOOD; COMPLICATION; KIDNEY DISEASES; LUPUS NEPHRITIS; PRE-ECLAMPSIA;

ANTIGENS, CD; ANTIPHOSPHOLIPID SYNDROME; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; KIDNEY DISEASES; LUPUS NEPHRITIS; MEMBRANE PROTEINS; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, CELL SURFACE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84908668408     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314529172     Document Type: Conference Paper

References (10)

1. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005 ; 365: 785-799
2. Sibai BM. Imitators of severe pre-eclampsia. Semin Perinatol. 2009 ; 33: 196-205
3. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003 ; 111: 649-658
4. Cuadrado MJ, Buendía P, Velasco F, et al. Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome. J Thromb Haemost. 2006 ; 4: 2461-2469
5. Williams FM, Parmar K, Hughes GR, Hunt BJ. Systemic endothelial cell markers in primary antiphospholipid syndrome. Thromb Haemost. 2000 ; 84: 742-746
6. Smadja D, Gaussem P, Roncal C, Fischer AM, Emmerich J, Darnige L. Arterial and venous thrombosis is associated with different angiogenic cytokine patterns in patients with antiphospholipid syndrome. Lupus. 2010 ; 19: 837-843
7. Robak E, Kierstan M, Cebula B, et al. Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosus. Lupus. 2009 ; 18: 332-341
8. Edelbauer M, Kshirsagar S, Riedl M, et al. Soluble VEGF receptor 1 promotes endothelial injury in children and adolescents with lupus nephritis. Pediatr Nephrol. 2012 ; 27: 793-800
9. Qazi U, Lam C, Karumanchi SA, Petri M. Soluble Fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus. J Rheumatol. 2008 ; 35: 631-634
10. Rhee JS, Young BC, Rana S. Angiogenic factors and renal disease in pregnancy. Case Rep Obstet Gynecol. 2011 ; 2011: 281 391-391